ALISO VIEJO, Calif., Oct. 5, 2015 /PRNewswire-USNewswire/ -- Metagenics, Inc., a nutrigenomics and lifestyle medicine company focused on improving health, today announced the launch of OmegaGenics SPM Active, a first-in-class nutritional supplement with specialized pro-resolving mediators (SPMs) designed to help support the resolution of the immune response—a natural response to tissue challenges from cellular damage, unhealthy diets and lifestyles. SPM production in the body decreases with age so SPM Active is particularly supportive of healthy aging.
When tissues in the body are challenged, the body reacts by developing a tailored immune response by recruiting cells and clearing cellular debris of affected tissues to help resume normal activity and maintain tissue health. An unresolved immune response may lead to discomfort and unwanted health conditions.
Recent research has led to the discovery that biologic resolution of the immune response is not a passive response, as traditionally believed, but rather an active, naturally-induced process that triggers the body to produce SPMs from the omega-3 fatty acids EPA and DHA. Through their pro-resolving properties, SPMs play an essential role in tissue health and healthy aging through the resolution of the immune response.
"The discovery of SPMs and the role they play in resolving immune responses and for chronic health concerns relating to healthy aging offers healthcare professionals a new approach to patient care," said John P. Troup, PhD, Chief Science Officer of Metagenics, Inc. "Through advanced technology, we've designed OmegaGenics SPM Active with standardized levels of SPMs found in select fractions of marine oils that complement and support the body's natural ability to resolve an immune response."
To find an authorized Metagenics healthcare practitioner or for more information about OmegaGenics SPM Active, visit www.Metagenics.com.
About Metagenics, Inc.
Metagenics, Inc. (www.metagenics.com) is a nutrigenomics and Lifestyle Medicine company dedicated to helping people live happier, healthier lives by realizing their genetic potential. Founded in 1983, Metagenics serves more than 75,000 healthcare providers worldwide through premium quality, science-based medical foods, nutritional formulas, and lifestyle therapy programs such as FirstLine Therapy to help their patients achieve a lifetime of good health. Metagenics' scientific staff—among the largest in the nutrigenomics industry—has published more than 80 articles in peer-reviewed journals and has been awarded more than 50 patents in USA and around the globe. The company collaborates with renowned medical experts to annually deliver more than 200 events designed to help healthcare professionals stay on the leading edge of lifestyle medicine and incorporate nutrition into their clinical practice.
Metagenics maintains its corporate headquarters in Aliso Viejo, CA; R&D headquarters in Gig Harbor, WA; and operating subsidiaries in Brussels, Belgium and Australia.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.